Skip to main content

Urgent need for a “next generation” Tinnitus solution

The alarming expansion of this dysfunction imposes scientific innovation suitable for this world- wide challenge. In 2022 the estimated total had risen to 750 million, of which 4-to-6 in Italy, with a constant rate of growth.

After about 50 years of therapies focused on acoustics (masking) or psycho-perceptive and behavioural dysfunction (eg.: TRT or CBT), the increase in sufferers has generated a sudden “proliferation of remedies of all kinds”.

For now, there are no solutions with clinical results comparable to what Acufree achieved in 2023 after 7 years of careful and repeatedly tested specialist patient care.

Multimodal therapies and a “next generation” technology such as Acufree

Acufree wants to be a change of pace on Tinnitus, after these years of disappointments in the reduction and above all in the “persistence” of relief over time.
The Tinnitech research team applied in advance the medical science developments now dominant for the most serious and incurable diseases: the need for multiple and synchronized therapies to achieve “clinical breakthroughs”.
In recent years there were remarkable successes in this field against HIV/AIDS, hepatitis and even some previously incurable cancers (source: Matchpoint, prof. Roberto Burioni). All due to multiple or multimodal therapies.
As a result of these innovations and trends in medicine, ACUFREE is today the only device with multiple (trimodal) therapy against tinnitus.

WHY Acufree is a NEXT GENERATION DEVICE

Synchronous multimodal therapy

It attacks tinnitus not just with one remedy, but with three simultaneously active remedies that progressively weaken acoustic and otoneurological dysfunction. A “multimodal” enriched with synchronous elements of inhibition and rebalancing of the areas at the origin of the dysfunction, which make Acufree effective with many types of tinnitus.

Endowed with a physiological and not only psychological effect

Aimed at restoring neuronal and acoustic nerve plasticity, activating the natural cellular microcirculation that promotes the reduction of toxic or inflammatory elements and the restoration of the crucial elasticity of the vibrating cells in the cochlear area.

Home-based and/or mobile

Which means ease but also regularity and reliability of use, effects, results.

 

Non-invasive with state-of-the-art electronics

It allows a higher level of monitoring and performance, including:

  • extended tonality and multi-frequency (optimised sound therapy);
  • possibility of greater acoustic (in decibels) and tinnitus diagnostic accuracy;
  • possibility of greater precision and therapeutic customisation;
  • propagation of the three beneficial synchronous waves in all the otological and neurological areas potentially involved and responsible for the pathology;
  • control and optimisation of clinical data even remotely for a greater guarantee of effective “product and therapeutic progress monitoring”, in coordination with the patient’s doctor.